Elisa Boscolo

14PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyHaematological tumoursMechanobiologyMicrofluidics and nanofluidicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 06, 2026
Polymeric rapamycin nanoparticles encapsulating ponatinib cause regression of venous malformations in mice.

|Apr 30, 2026
Constitutive, Mosaic Expression of TIE2 p.L914F During Mouse Development Causes Venous Malformation.

|Feb 09, 2026
Constitutive, mosaic expression of TIE2 p.L914F during mouse development causes formation of venous malformation.

Lindsay J Bischoff, Chhiring Sherpa, Sandra Schrenk

|Oct 23, 2025
Semaphorin 3A and 3F Promote Lumen Expansion in TIE2-Mutated Venous Malformation.

Sandra Schrenk, Chhiring Sherpa, Lindsay J Bischoff

|Oct 11, 2025
Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling.

Lindsay J Bischoff, Sandra Schrenk, Kara Soroko

|Aug 08, 2025
Semaphorin 3A and 3F overexpression in TIE2 hyperactive endothelial cells contribute to the pathological lumen expansion in venous malformation.

Sandra Schrenk, Chhiring Sherpa, Lindsay J Bischoff

Pageof 3

Frequent Collaborators

4 joint publications

Timothy D Le Cras

2 joint publications

Denise M Adams

2 joint publications

Lindsay J Bischoff

1 joint publications

Mara Coyan